Luca Delli Colli

Luca Delli Colli

Auto-generated profile, based on publicly available information

Luca Delli Colli

Department of Medicine McGill University Montreal Quebec Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
LCLuca Delli Colli
Luca Delli Colli
SGSofianne Gabrielli
Sofianne Gabrielli
EAElissa M. Abrams
Elissa M. Abrams
AOAndrew O'KEefe
Andrew O'KEefe
JPJennifer L.P. Protudjer
Jennifer L.P. Protudjer
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan

7 September 2023 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
LCLuca Delli Colli
Luca Delli Colli
AAAdnan Al Ali
Adnan Al Ali
SGSofianne Gabrielli
Sofianne Gabrielli
MCMarina Delli Colli
Marina Delli Colli
PMPasquale Mule
Pasquale Mule
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan

5 March 2025 in International Archives of Allergy and Immunology
Verified
Journal Article
Open access
LCLuca Delli Colli
Luca Delli Colli
JYJoshua Yu
Joshua Yu
DLDerek Lanoue
Derek Lanoue
AMAdhora Mir
Adhora Mir
CCCasey G. Cohen
Casey G. Cohen
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan
Introduction: Oral food challenges are the gold standard for diagnosis and reactivity thresholds but are resource intensive and high risk for reactions. Limited data on factors associated with increased risk of positive oral food challenges exist. We aimed to assess factors associated with positive oral food challenges and create a model to predict cow milk oral food challenge outcomes. Methods: Children aged 5–18 being considered for cow’s milk oral immunotherapy underwent a single-blind, placebo-controlled food challenge to cow’s milk, with either positive (reaction) or negative (tolerance) outcomes. Initial factors recorded included sex, age, history of asthma, eczema, allergic rhinitis, prior epinephrine use for cow’s milk-induced reactions, skin prick test size, serum levels of immunoglobulin E antibodies to α-lactalbumin, β-lactoglobulin, and casein, and log-transformed values. Stepwise backward multivariate Firth bias-reduced logistic regression was used to create the final model, and performance was assessed with receiver operator characteristic curves. Results: A total of 111 children underwent an oral food challenge, 103 patients reacted, and 8 tolerated the challenge. Univariate analysis showed skin prick test size, previous epinephrine use, history of asthma, and log-transformed α-lactalbumin, β-lactoglobulin, and casein were significantly associated with positive oral food challenge. The multivariate model included two factors: log-transformed casein (aOR 2.4; 95% CI: 1.4–5.9; p < 0.001) and previous epinephrine use (aOR 6.5; 95% CI: 1.2–68.0; p = 0.03). The final model showed good discriminatory performance (AUC 0.928; 95% CI: 0.83–0.98). In comparison, a univariate model using only the skin prick test (OR 1.44, 95% CI: 1.1–2.0; p = 0.002) had worse discriminatory performance (AUC 0.83; 95% CI: 0.64–0.93). Conclusion: The study suggests that logistic multivariate models, including log-transformed casein and previous epinephrine use, may help predict oral food challenge outcomes in pediatric patients. Future studies are needed to validate this with larger datasets.

22 December 2025 in Plastic Surgery
Verified
Journal Article
Open access
MAMeshari AlNesef
Meshari AlNesef
RERawan ElAbd
Rawan ElAbd
LCLuca Delli Colli
Luca Delli Colli
DZDino Zammit
Dino Zammit
Earlobe keloids are difficult to manage due to their high recurrence rates and the challenges of applying consistent compression over the ear's complex shape. Common treatments, including surgical excision, intralesional corticosteroid injections, cryotherapy, laser therapy, and radiotherapy, often have recurrence rates exceeding 50 percent when used alone. Combining surgical excision with adjuvant measures can significantly improve outcomes. We describe a novel, low cost, time efficient, and easily fabricated compression device used alongside core excision, low tension closure, and intralesional corticosteroids. Two 25-gauge syringe hubs are removed from the syringe and modified with cautery to create suture channels. They are soaked in chlorhexidine or alcohol, layered with xeroform gauze, and applied bilaterally to the earlobe using nylon sutures in a horizontal mattress or figure-of-eight configuration. Worn continuously for six months, the device delivers sustained, conforming compression, integrates recurrence-reducing principles, and offers a practical alternative to commercial or custom 3D printed devices.